Hyderabad-based Biological E Limited’s Covid-19 vaccine Corbevax has emerged as the first vaccine to bag approval from the Drug Controller General of India for use as a heterologous booster dose, for those aged 18 years and above, after 6 months of administration of the second dose of either Covaxin or Covishield.
source https://timesofindia.indiatimes.com/india/corbevax-gets-nod-as-booster-jab-for-covaxin-covishield-recipients/articleshow/92004928.cms
0 Comments
Don't post spam messages